
Alcohol and opioid abuse have pervasive and detrimental consequences from the individual to societal level. The extent of genetic contribution to alcoholism has been studied for decades, yielding speculative and often inconsistent results since the previous discovery of two pharmacokinetic variants strongly protective against alcoholism. The neurobiology of addiction involves innumerate genes with combinatorial and epistatic interactions, creating a difficult landscape for concrete conclusions. In contrast, pharmacogenomic variation in the treatment of alcoholism yields more immediate clinical utility, while also emphasizing pathways crucial to the progression of addiction. An improved understanding of genetic predisposition to alcohol abuse has inherent significance for opioid addiction and treatment, as the two drugs induce the same reward pathway. This review outlines current knowledge, treatments, and research regarding genetic predisposition to alcoholism, focusing on pharmacodynamic variation within the dopaminergic system and shared implications for opioid abuse. Multifaceted and highly polygenic, the phenotype of addiction seems to grow more complex as new research extends the scope of its impact on the brain, body, and progeny.
Citation: Catherine Demery-Poulos, Joseph M. Chambers. Genetic variation in alcoholism and opioid addiction susceptibility and treatment: a pharmacogenomic approach[J]. AIMS Molecular Science, 2021, 8(4): 202-222. doi: 10.3934/molsci.2021016
[1] | Saima Rashid, Sobia Sultana, Bushra Kanwal, Fahd Jarad, Aasma Khalid . Fuzzy fractional estimates of Swift-Hohenberg model obtained using the Atangana-Baleanu fractional derivative operator. AIMS Mathematics, 2022, 7(9): 16067-16101. doi: 10.3934/math.2022880 |
[2] | M. S. Alqurashi, Saima Rashid, Bushra Kanwal, Fahd Jarad, S. K. Elagan . A novel formulation of the fuzzy hybrid transform for dealing nonlinear partial differential equations via fuzzy fractional derivative involving general order. AIMS Mathematics, 2022, 7(8): 14946-14974. doi: 10.3934/math.2022819 |
[3] | Saima Rashid, Fahd Jarad, Fatimah S. Bayones . On new computations of the fractional epidemic childhood disease model pertaining to the generalized fractional derivative with nonsingular kernel. AIMS Mathematics, 2022, 7(3): 4552-4573. doi: 10.3934/math.2022254 |
[4] | Shams A. Ahmed, Tarig M. Elzaki, Abdelgabar Adam Hassan, Husam E. Dargail, Hamdy M. Barakat, M. S. Hijazi . Applications of Elzaki transform to non-conformable fractional derivatives. AIMS Mathematics, 2025, 10(3): 5264-5284. doi: 10.3934/math.2025243 |
[5] | Yousef Jawarneh, Humaira Yasmin, Abdul Hamid Ganie, M. Mossa Al-Sawalha, Amjid Ali . Unification of Adomian decomposition method and ZZ transformation for exploring the dynamics of fractional Kersten-Krasil'shchik coupled KdV-mKdV systems. AIMS Mathematics, 2024, 9(1): 371-390. doi: 10.3934/math.2024021 |
[6] | Yousef Jawarneh, Humaira Yasmin, M. Mossa Al-Sawalha, Rasool Shah, Asfandyar Khan . Numerical analysis of fractional heat transfer and porous media equations within Caputo-Fabrizio operator. AIMS Mathematics, 2023, 8(11): 26543-26560. doi: 10.3934/math.20231356 |
[7] | Yudhveer Singh, Devendra Kumar, Kanak Modi, Vinod Gill . A new approach to solve Cattaneo-Hristov diffusion model and fractional diffusion equations with Hilfer-Prabhakar derivative. AIMS Mathematics, 2020, 5(2): 843-855. doi: 10.3934/math.2020057 |
[8] | Safyan Mukhtar, Wedad Albalawi, Faisal Haroon, Samir A. El-Tantawy . Analytical insight into fractional Fornberg-Whitham equations using novel transform methods. AIMS Mathematics, 2025, 10(4): 8165-8190. doi: 10.3934/math.2025375 |
[9] | Muhammad Imran Liaqat, Sina Etemad, Shahram Rezapour, Choonkil Park . A novel analytical Aboodh residual power series method for solving linear and nonlinear time-fractional partial differential equations with variable coefficients. AIMS Mathematics, 2022, 7(9): 16917-16948. doi: 10.3934/math.2022929 |
[10] | Rasool Shah, Abd-Allah Hyder, Naveed Iqbal, Thongchai Botmart . Fractional view evaluation system of Schrödinger-KdV equation by a comparative analysis. AIMS Mathematics, 2022, 7(11): 19846-19864. doi: 10.3934/math.20221087 |
Alcohol and opioid abuse have pervasive and detrimental consequences from the individual to societal level. The extent of genetic contribution to alcoholism has been studied for decades, yielding speculative and often inconsistent results since the previous discovery of two pharmacokinetic variants strongly protective against alcoholism. The neurobiology of addiction involves innumerate genes with combinatorial and epistatic interactions, creating a difficult landscape for concrete conclusions. In contrast, pharmacogenomic variation in the treatment of alcoholism yields more immediate clinical utility, while also emphasizing pathways crucial to the progression of addiction. An improved understanding of genetic predisposition to alcohol abuse has inherent significance for opioid addiction and treatment, as the two drugs induce the same reward pathway. This review outlines current knowledge, treatments, and research regarding genetic predisposition to alcoholism, focusing on pharmacodynamic variation within the dopaminergic system and shared implications for opioid abuse. Multifaceted and highly polygenic, the phenotype of addiction seems to grow more complex as new research extends the scope of its impact on the brain, body, and progeny.
alcohol dehydrogenase 1B;
alcohol dehydrogenase 1C;
aldehyde dehydrogenase 2;
alcohol use disorder;
Alcohol Use Disorder Identification Test – Consumption;
calcium-bis (N-acetylhomotaurinate);
cytochrome P450 family 2, subfamily e, polypeptide 1;
differentially-methylated cytosine;
dopamine receptor D2;
family with sequence similarity 107 member B;
FIC domain protein adenylyltransferase;
fat, mass, and obesity-associated gene;
fucosyltransferase 2;
gamma aminobutyric acid;
glucokinase receptor;
G-protein coupled receptor;
genome-wide association study;
calcium-activated potassium channel;
potassium voltage-gated channel subfamily B member 1;
potassium calcium-activated channel subfamily M alpha 1;
potassium voltage-gated channel subfamily Q member 5;
inwardly-rectifying potassium channel;
kinesin family member 2A;
klotho beta;
kappa opioid receptor;
voltage-dependent potassium channel;
rRNA promoter binding protein;
mitotic arrest deficient 2 like 2;
nucleus accumbens;
N-methyl-D-aspartate;
µ opioid receptor 1;
origin recognition complex subunit 4;
cAMP-specific 3′,5′-cyclic phosphodiesterase 4B;
prefrontal cortex;
phosphatidate phosphohydrolase type 2b;
protein tyrosine phosphatase receptor type M;
Reward Deficiency Syndrome;
ring finger protein 165;
SIX homeobox 3;
solute carrier family 39 member 8;
solute carrier family 39 member 13;
ventral tegmental area;
polypeptide N-acetylgalactosaminyltransferase 17
In recent years, fractional differential equations (FDEs) have garnered substantial attention for their capacity to simulate intricate phenomena in a variety of disciplines, including finance, engineering, biology, and physics. These equations, which generalize classical differential equations to fractional-order derivatives, enable more precise description of heritable properties and memory in a variety of natural and man-made systems. Among these, local fractional differential equations (LFDEs) have emerged as a potent instrument for documenting the dynamical behavior of fractal and disordered domains. Nevertheless, the nonlinearity of these equations and the intricate interaction between fractional derivatives and stochastic components present substantial challenges when dealing with randomness or uncertainty. The individuals who have been gathered will be displayed using software.
A nonlinear differential equation with extensive applications in control theory, fluid mechanics, population dynamics, and quantum mechanics, the Riccati differential equation is a well-known equation. Fractional Riccati differential equations play an important role in modeling nonlinear systems that occur in physical and engineering applications. Fractional Riccati differential equations play an important role in modeling nonlinear systems that occur in physical and engineering applications. Adomian decomposition method, He's homotopy approximation, variational iteration method, and various numerical methods have been used in solving these equations. Momani and Shawagfeh [1] obtained accurate and convergent results using the decomposition method for solving fractional Riccati differential equations. Merdan [2] investigated solutions to the fractional Riccati differential equation using modified Riemann-Liouville derivatives. Abbasbandy [3] successfully applied the iterated He's homotopy perturbation method to the quadratic Riccati differential equation. He [4] introduced an approximate analytical method for fractional seepage flow, laying the groundwork for later applications. Jafari and Tajadodi [5] utilized the variational iteration method for solving fractional Riccati equations effectively. Khader [6] provided a numerical approach to solve these equations, while Khader, Mahdy, and Mohamed [7] worked on approximate solutions. Additionally, Khader [8] extended the numerical treatment to fractional diffusion equations. Finally, Khaniyev and Merdan [9] analyzed the fractional Riccati equation in detail and proposed further improvements.
The local fractional Riccati differential equation (LFRDE), its fractional counterpart, provides sophisticated modeling capabilities for systems with fractal-like structures. The applicability of these equations to problems where uncertainty or noise is a critical factor, such as stochastic processes or chaotic systems, is further enhanced by the inclusion of randomness. Nevertheless, the process of obtaining exact or approximate solutions to random local fractional Riccati differential equations (RLFRDEs) is a multifaceted endeavor that necessitates the use of efficient and robust solution techniques.
The Adomian decomposition method (ADM) [10,11,12,13] and the Elzaki transform method (ETM) are among the numerous methods that have been devised in recent years to solve fractional differential equations. The Elzaki transform technique was designed as a powerful tool for solving differential and integro-differential problems. Elzaki and Ezaki [14] provided a fundamental method for solving integro-differential equations with the Elzaki transform. In the same year, they expanded the method's scope by describing its applicability to higher order ordinary differential equations [15] and variable coefficient differential equations [16]. Mahgob and Elzaki [17,18,19] used the Elzaki transform to solve Volterra type integral equations and partial integro-differential equations using various special functions (e.g., the Bulge function). Bhadane et al. [20] used this approach to solve one-dimensional groundwater recharge issues in hydrogeology and showed that it is useful in engineering. Hilal and Elzaki [21] provided an analytical solution for the telegraph equation by demonstrating that the Elzaki transform is a modified version of the Sumudu transform. Elzaki and Ezaki [22] adapted the Elzaki transform to systems of partial differential equations and shown that the approach is also applicable to system solutions. Ziane and Cherif [23] provided an enhanced version of the approach that solves nonlinear partial differential equations using the Elzaki transform decomposition method. Finally, Shah et al. [24] successfully implemented the Elzaki transform to fractional multidimensional telegraph equations, achieving remarkably accurate results by combining the approach with the Adomian decomposition methodology.
The ETM offers an efficient framework for systematically transforming and solving differential equations, while the ADM is renowned for its capacity to decompose nonlinear problems into a set of simpler components. The Elzaki-Adomian decomposition method (EADM) is a prospective hybrid technique that capitalizes on the assets of both methods by combining these two approaches. The EADM has not yet been extensively investigated in the context of arbitrary local fractional differential equations, despite its potential.
This paper presents the EADM [25,26,27,28,29,30] as a novel technique for solving random local fractional Riccati differential equations. The suggested approach adeptly integrates the decomposition features of ADM with the transformation attributes of ETM, offering a robust instrument to tackle the difficulties presented by nonlinearity, unpredictability, and fractional order derivatives. The primary aims of this study are to establish a systematic framework for implementing EADM in RLFRDEs, to showcase its efficacy and precision via illustrative cases, and to evaluate its performance against existing methodologies. This work aims to introduce a novel analytical method for solving the fractional-time Riccati problem through the use of the local derivative. The suggested method employs the Elzaki transform and fractional local derivative in conjunction with Adomian polynomials to get the approximate analytical solution of the fractional time Riccati problem. Three numerical implementations are provided to illustrate the proposed approach for exponential, uniform, and normal random variables, with initial conditions selected from perfectly continuous distributions for the nonlinear Riccati equation. The alteration in the solution due to the fractional parameter is examined by numerical and graphical analyses.
The subsequent sections of this work are structured as follows: Section 2 provides the mathematical foundation and terminology pertinent to fractional calculus, local fractional derivatives, and stochastic differential equations. Section 3 delineates the Adomian-Elzaki method and its use in RLFRDEs. Section 4 provides numerical examples to substantiate the proposed method and emphasizes its benefits compared to conventional approaches. Section 5 ultimately finishes the report by discussing the research findings and prospective future directions in this field.
Here, we present some basic definitions of local fractional derivative that are important to our research.
Definition 2.1. Local fractional derivative of 𝒻(x) of order σ at x=x0,0<σ≤1:
𝒻(σ)(x)=dσ𝒻dxσ|x=x0=limx→x0Δσ𝒻(x)−𝒻(x0)(x−x0)σ. | (2.1) |
Here, 𝒻(σ)(x)≅limx→x0Г(1+σ)[𝒻(x)−𝒻(x0)](x−x0)σ.
The local fractional partial differential operator of order σ is given by Kolwankar and Gangal [31,32],
∂σω(x0,t)∂tσ=limx→x0Δσ(ω(x0,t)−ω(x0−t0))(t−t0)σ. | (2.2) |
Here, Δσ(U(x0,t)−U(x0−t0))≅Г(1+σ)[U(x0,t)−U(x0−t0)].
Definition 2.2. Let F(t) be a function that is defined for t greater than 0. The Elzaki transform of F(t) is defined as follows:
E(F(t))=v∫∞0e−tv𝒻(t)dt. | (2.3) |
New transformation operatör [33] LFEσ:𝒻(x)→Tσ(v):
LFEσ{𝒻(x)}=LFEσ{∑∞k=0akxkσ}=∑∞k=0Г(1+kσ)akvkσ+2σ. | (2.4) |
For example,
𝒻(x)=Eσ(iσxσ), |
LFEσ{Eσ(iσxσ)}=LFEσ{∞∑k=0ikσxkσГ(1+kσ)}=∞∑k=0Г(1+kσ)ikσГ(1+kσ)vkσ+2σ=∞∑k=0ikσvkσ+2σ, |
and if 𝒻(x)=xσГ(1+σ),
LFEσ{xσГ(1+σ)}=Г(1+σ)1Г(1+σ)vσ+2σ=v3σ. |
Definition.2.3. [33] Local fractional Elzaki transform of the function 𝒻(x) of order σ:
LFEσ{𝒻(x)}=Tσ(v)=vσГ(1+σ)∫∞0Eσ(−xσvσ)𝒻(x)(dx)σ,0<σ≤1. | (2.5) |
The inverse transformation may be derived as follows:
LFE−1σ{Tσ(v)}=𝒻(x). |
Teorem 2.1. [33] Elzaki transform of local fractional derivative:
If LFEσ{𝒻(x)}=Tσ(v),
LFEσ{Dσ0+𝒻(x)}=1vσTσ(v)−vσ𝒻(0),0<σ≤1, | (2.6) |
and
LFEσ{Dnσ0+𝒻(x)}=1vnσTσ(v)−∑n−1k=0v(k−n+2)σ𝒻(kσ)(0),0<σ≤1. | (2.7) |
Teorem 2.2. [33] Elzaki transform of local fractional integral
LFEσ{𝒻(x)}=Tσ(v), |
therefore,
LFEσ{0Iσx𝒻(x)}=vσTσ(v). |
Teorem 2.3. [34] Local fractional Elzaki transformations of various special functions are presented below:
ⅰ) 𝒻(x)=1, Eσ(x)=∑∞k=0xkσГ(1+kσ),
LFEσ{1}=Tσ(v)=vσГ(1+σ)∫∞0Eσ(−xσvσ)1(dx)σ=v2σ. | (2.8) |
ⅱ) LFEσ{xσ}=Г(1+σ)v3σ, LFEσ{xσГ(1+σ)}=v3σ,
LFEσ{xnσ}=Г(1+σ)v2σ+nσ. | (2.9) |
ⅲ) 𝒻(x)=Eσ((ax)σ),
LFEσ{Eσ((ax)σ)}=v2σ1−(av)σ. | (2.10) |
ⅳ) 𝒻(x)=xσГ(1+σ)Eσ((ax)σ),
LFEσ{xσГ(1+σ)Eσ((ax)σ)}=v3σ(1−(av)σ)2. | (2.11) |
This section presents the Elzaki-Adomian decomposition method [35] for the solution of fractional ordinary differential equations and equation systems when the fractional Riccati differential equation is expressed as
Dαty(t)=p(t)+q(t)y(t)+r(t)y(t)2, | (2.12) |
and let y(0)=B be the initial condition, then the solution of the equation is y(t), and Dαt≡CDαt is a Caputo fractional derivative operator with 0<α≤1. The real-valued functions p(t),q(t), and r(t) are well-known. Using the Elzaki transform in Eq (2.3),
y(v)=v2y(0)+vαE[p(t)]+vαE[q(t)y(t)]+vαE[r(t)y(t)2] | (2.13) |
is obtained. Then, if the inverse Elzaki transform of the expression (13) is taken,
y(t)=y(0)+E−1[vαE[p(t)]]+E−1[vαE[q(t)y(t)]]+E−1[vαE[r(t)y(t)2]]. | (2.14) |
The Adomian decomposition approach posits that the function y may be expressed as an infinite series [36,37].
y(t)=∑∞n=0yn(t)=y0+y1+y2+…, | (2.15) |
where yn can be defined recursively. This approach also presupposes that the nonlinear operator Ny may be expressed as an infinite polynomial series.
Ny=∑∞n=0An, | (2.16) |
where An=An(y0,y1,y2,…,yn) is an Adomian polynomial defined,
An(y0,y1,y2,…,yn)=1n!dndλn[N(∑nk=0λkyk)]λ=0,n=0,1,2,… |
where λ is a parameter. The Adomian polynomial An can be defined as follows:
A0=10!d0dλ0[N(∑0k=0λkyk)]λ=0=N(y0), |
A1=11!d1dλ1[N(∑1k=0λkyk)]λ=0=y1N'(y0), |
A2=12!d2dλ2[N(∑2k=0λkyk)]λ=0=y2N'(y0)+y122!N''(y0). |
If we substitute (2.15) and (2.16) into (2.14),
∞∑n=0yn(t)=y(0)+E−1[vαE[p(t)]]+E−1[vαE[q(t)∞∑n=0yn(t)]]+E−1[vαE[∞∑n=0An]]. | (2.17) |
If the terms of the same order in Eq (2.17) are equated,
y0=y(0)+E−1[vαE[p(t)]],y1=E−1[vαE[A0]]+E−1[vαE[qy0]],y2=E−1[vαE[A1]]+E−1[vαE[qy1]],y3=E−1[vαE[A2]]+E−1[vαE[qy2]],⋮ | (2.18) |
Consequently, the Elzaki-Adomian decomposition approach yields the recursive relation for the solution of the ordinary differential equation (2.18) as follows:
y0=y(0)+E−1[vαE[p(t)]], | (2.19) |
yn+1=E−1[vαE[An]]+E−1[vαE[qyn]],n=0,1,2,… |
Define the Banach space C[0,T] consisting of all continuous functions on the interval [0,T] with a supremum norm. In this part, we examine the functions y(t) and yn(t)∈C[0,T].
Theorem 3.1. (Theorem of uniqueness [38,39]) The unique solution for the nonlinear fractional differential Eq (2.12) derived by Elzaki-Adomian is valid for 0<γ<1.
Proof. The resolution of nonlinear FODEs in Eq (2.12) is delineated as follows:
y(t)=∑∞n=0yn(t), | (3.1) |
{n=0;y0=y(0)+E−1[vαE[p(t)]],n≥0;yn+1=E−1[vαE[An]]+E−1[vαE[qyn]]. | (3.2) |
Assuming that y and z are two distinct solutions of Eq (3.2), we may derive the following using the previously described equation:
|y–z|=|E−1{[vαE[p(t)+q(t)(y−z)+r(t)(y2−z2)]]}|. | (3.3) |
Utilizing the convolution theory for the Elzaki transform, it is derived as
|y–z|≤∫t0(|q(y–z)|+|r(y2−z2)|)(t−τ)βΓ(1+β)dτ≤∫t0(|q||(y–z)|+|r||(y–z)(y+z)|)(t−τ)βΓ(1+β)dτ. | (3.4) |
Subsequently, applying the integral mean-value theorem, it results in
|y–z|≤(|q||(y–z)|+|r||(y–z)(Φ+Ω)|)T, |
γ=(|q|+|r||(Φ+Ω)|)T, |
|y–z|≤γ|(y–z)|,(1−γ)|y–z|≤0. |
Therefore, |y–z|=0, as 0<γ<1. Consequently, y=z. This demonstrates the solution's distinctiveness.
Theorem 3.2. (Convergence teorem [40,41]) Let X be a Banach space and H:X→X be a nonlinear mapping. Should the inequality
‖H(y)–H(z)‖≤γ‖y–z‖,∀y,z∈X. | (3.5) |
If it exists, then H possesses a fixed point according to Banach's fixed point theorem [41]. Moreover, for the arbitrary selection of y0 and y1 in X, the sequence generated by the Elzaki-ADM converges to a fixed point of H.
‖ym–yn‖≤γn1−γ‖y1–y0‖,∀Ψ,Φ∈X. | (3.6) |
Proof. Consider a Banach space (C[J],‖.‖) comprising all continuous functions on J, with the norm defined as ‖h(ξ)‖=maxξ∈J|h(ξ)|.
We now illustrate that the sequence {yn} constitutes a Cauchy sequence within the Banach space:
‖ym–yn‖=maxξ∈J|ym–yn|=maxξ∈J|E−1{[vαE[p(t)+q(t)(ym−1−yn−1)+r(t)(y2m−1–y2n−1)]]}|≤maxξ∈J[E−1{[vαE[p(t)+q(t)|ym−1−yn−1|+r(t)|y2m−1–y2n−1|]]}]. |
Currently, the convolution theorem for Laplace transform is employed to provide the following:
‖ym–yn‖≤maxξ∈J[∫ξ0[p(t)+q(τ)|ym−1−yn−1|+r(τ)|y2m−1–y2n−1|](t−τ)βΓ(1+β)dτ]≤maxξ∈J[∫ξ0(p(t)+q(τ)|ym−1−yn−1|+r(τ)|(ym−1–yn−1)(Φ+Ω)|)(t−τ)βΓ(1+β)dτ]. |
Next, we obtain the result by employing the integral mean value theorem [41].
‖ym–yn‖≤maxξ∈J[(p+q|ym−1−yn−1|+r|(ym−1–yn−1)(Φ+Ω)|)T], |
‖ym–yn‖≤γ‖ym−1–yn−1‖. |
Let m=n+1, then we have
‖yn+1–yn‖≤γ‖yn–yn−1‖≤γ2‖yn−1–yn−2‖≤⋯≤γn‖y1–y0‖. |
Utilizing the triangular inequality, it generates the following:
‖ym–yn‖≤‖yn+1–yn‖+‖yn+2–yn+1‖+⋯+‖ym–ym−1‖≤[γn+γn+1+⋯+γm−1]‖y1–y0‖≤γn[1+γ+γ2+⋯+γm−n−1]‖y1–y0‖≤γn[1−γm−n−11−γ]‖y1–y0‖. |
Because γ∈(0,1), so 1−γm−n−1<1, then we have
‖ym–yn‖≤γn1−γ‖y1–y0‖. |
Although ‖y1–y0‖<∞, as m approaches infinity, ‖ym–yn‖ approaches zero.
Consequently, the sequence {yn} is a Cauchy sequence in C[J] and is therefore convergent.
Example 1.
CDαty(t)=−y2(t)+1,0<α≤1,y(0)=B, | (3.7) |
B U(ξ=2,η=4), |
in this context, where B denotes a random variable with a uniform distribution, solve the local fractional order Riccati differential equation given the initial condition using the Elzaki-Adomian decomposition method and examine the probabilistic characteristics.
Solution:
Once the Elzaki-Adomian decomposition method was used on Eq (3.7), the following results were obtained:
y0=y(0)+E−1[vαE[1]],yn+1=−E−1[vαE[An]], |
y0=B+E−1[vαv2]=B+E−1[vα+2]=B+tαГ(α+1). |
For n=0,
y1=−E−1[vαE[A0]], |
A0=N(y0)=y02=B2+2BtαГ(α+1)+t2αГ2(α+1), |
y1=−E−1[vαE[B2+2BtαГ(α+1)+t2αГ2(α+1)]]=−E−1[vα{B2v2+2Bvα+2+1Г2(α+1)Г(2α+1)v2α+2}]=−E−1[B2vα+2+2Bv2α+2+v3α+2Г(2α+1)Г2(α+1)]=−B2tαГ(α+1)−2Bt2αГ(2α+1)−Г(2α+1)Г2(α+1)Г(3α+1)t3α. |
For n=1,
y2=−E−1[vαE[A1]], |
A1=y1N'(y0)=2y0y1=2(B+tαГ(α+1))(−B2tαГ(α+1)−2Bt2αГ(2α+1)−Г(2α+1)Г2(α+1)Г(3α+1)t3α)=−2B3tαГ(α+1)−4B2t2αГ(2α+1)−2BГ(2α+1)t3αГ2(α+1)Г(3α+1)−2B2t2αГ(α+1)2−4Bt3αГ(2α+1)Г(α+1)−2Г(2α+1)t4αГ2(α+1)Г(3α+1)Г(α+1), |
y2=−E−1[vαE[−2B3tαГ(α+1)−4B2t2αГ(2α+1)−2BГ(2α+1)t3αГ2(α+1)Г(3α+1)−2B2t2αГ(α+1)2−4Bt3αГ(2α+1)Г(α+1)−2Г(2α+1)t4αГ2(α+1)Г(3α+1)Г(α+1)]]=−E−1[−2B3Г(α+1)v2α+2Г(α+1)−4B2Г(2α+1)v3α+2Г(2α+1)−2BГ(2α+1)Г(3α+1)v4α+2Г2(α+1)Г(3α+1)−2B2Г(2α+1)v3α+2Г(α+1)2−4BГ(3α+1)v4α+2Г(2α+1)Г(α+1)−2Г(2α+1)Г(4α+1)v5α+2Г2(α+1)Г(3α+1)Г(α+1)]=−E−1[−2B3v2α+2−4B2v3α+2−2BГ(2α+1))v4α+2Г2(α+1)−2B2Г(2α+1)v3α+2Г(α+1)2−4BГ(3α+1)v4α+2Г(2α+1)Г(α+1)−2Г(2α+1)Г(4α+1)v5α+2Г2(α+1)Г(3α+1)Г(α+1)]=2B3t2αГ(2α+1)+4B2t3αГ(3α+1)+2BГ(2α+1))t4αГ2(α+1)Г(4α+1)+2B2Г(2α+1)t3αГ(α+1)2Г(3α+1)+4BГ(3α+1)t4αГ(2α+1)Г(α+1)Г(4α+1)+2Г(2α+1)Г(4α+1)t5αГ2(α+1)Г(5α+1)Г(3α+1)Г(α+1), |
y(t)=y0+y1+y2+…=B+tαГ(α+1)−B2tαГ(α+1)−2Bt2αГ(2α+1)−Г(2α+1)Г2(α+1)Г(3α+1)t3α+2B3t2αГ(2α+1)+4B2t3αГ(3α+1)+2BГ(2α+1))t4αГ2(α+1)Г(4α+1)+2B2Г(2α+1)t3αГ(α+1)2Г(3α+1)+4BГ(3α+1)t4αГ(2α+1)Г(α+1)Г(4α+1)+2Г(2α+1)Г(4α+1)t5αГ2(α+1)Г(5α+1)Г(3α+1)Г(α+1)+… |
A solution is achieved. In particular, the absolute error diagrams and the comparison of the exact solution with the Elzaki-Adomian solution for B=0 and α=1 are provided below.
The characteristics of the random variable X follow a uniform distribution, denoted as X U(ξ,η). Employing the moment generating function of the uniform distribution
MX(t)=E[etX]=eηt−eξt(η−ξ)t, |
the first moment and variance of the random variable B U(ξ,η) are
E[B]=ξ+η2,E[B2]=ξ2+ξη+η23,E[B3]=ξ3+ξ2η+ξη2+η34, |
Var[B]=(ξ−η)212,Var[B2]=(4ξ4−ξ3η−6ξ2η2−ξη3+4η4)45, |
Var[B3]=9ξ6+2ξ5η−5ξ4η2−12ξ3η3−5ξ2η4+2ξη5+9η6112 |
is found [42,43]. Let us find the expected value and variance of the expression (3.8).
E(y(t))=E(B)+tαГ(α+1)−E(B2)tαГ(α+1)−2E(B)t2αГ(2α+1)−Г(2α+1)Г2(α+1)Г(3α+1)t3α+2E(B3)t2αГ(2α+1)+4E(B2)t3αГ(3α+1)+2E(B)Г(2α+1))t4αГ2(α+1)Г(4α+1)+2E(B2)Г(2α+1)t3αГ(α+1)2Г(3α+1)+4E(B)Г(3α+1)t4αГ(2α+1)Г(α+1)Г(4α+1)+2Г(2α+1)Г(4α+1)t5αГ2(α+1)Г(5α+1)Г(3α+1)Г(α+1)+… |
=(ξ+η2)+tαГ(α+1)−(ξ2+ξη+η23)tαГ(α+1)−2(ξ+η2)t2αГ(2α+1)−Г(2α+1)Г2(α+1)Г(3α+1)t3α+2(ξ3+ξ2η+ξη2+η34)t2αГ(2α+1)+4(ξ2+ξη+η23)t3αГ(3α+1)+2(ξ+η2)Г(2α+1))t4αГ2(α+1)Г(4α+1)+2(ξ2+ξη+η23)Г(2α+1)t3αГ(α+1)2Г(3α+1)+4(ξ+η2)Г(3α+1)t4αГ(2α+1)Г(α+1)Г(4α+1)+2Г(2α+1)Г(4α+1)t5αГ2(α+1)Г(5α+1)Г(3α+1)Г(α+1)+… |
Expected value for special values ξ=2 and η=4,
E(y(t))=3+tαГ(α+1)−28tα3Г(α+1)−6t2αГ(2α+1)−Г(2α+1)t3αГ2(α+1)Г(3α+1)+60t2αГ(2α+1)+112t3α3Г(3α+1)+6Г(2α+1))t4αГ2(α+1)Г(4α+1)+56Г(2α+1)t3α3Г(α+1)2Г(3α+1)+12Г(3α+1)t4αГ(2α+1)Г(α+1)Г(4α+1)+2Г(2α+1)Г(4α+1)t5αГ2(α+1)Г(5α+1)Г(3α+1)Г(α+1)+… |
Var(y(t))=Var(B)+Var(B2)t2αГ(α+1)2+4Var(B)t4αГ(2α+1)2+4Var(B3)t4αГ(2α+1)2+16Var(B2)t6αГ(3α+1)2+4Var(B)Г(2α+1)2t8αГ4(α+1)Г(4α+1)2+2Var(B2)Г(2α+1)2t6αГ(α+1)4Г(3α+1)2+16Var(B)Г(3α+1)2t8αГ(2α+1)2Г(α+1)2Г(4α+1)2=((ξ−η)212)+((4ξ4−ξ3η−6ξ2η2−ξη3+4η4)45)t2αГ(α+1)2+4((ξ−η)212)t4αГ(2α+1)2+4(9ξ6+2ξ5η−5ξ4η2−12ξ3η3−5ξ2η4+2ξη5+9η6112)t4αГ(2α+1)2+16((4ξ4−ξ3η−6ξ2η2−ξη3+4η4)45)t6αГ(3α+1)2+4((ξ−η)212)Г(2α+1)2t8αГ4(α+1)Г(4α+1)2+2((4ξ4−ξ3η−6ξ2η2−ξη3+4η4)45)Г(2α+1)2t6αГ(α+1)4Г(3α+1)2+16((ξ−η)212)Г(3α+1)2t8αГ(2α+1)2Г(α+1)2Г(4α+1)2. |
For special values of ξ=2andη=4, the variance is
Var(y(t))=13+12.0889t2αГ(α+1)2+43t4αГ(2α+1)2+1044.6t4αГ(2α+1)2+193.4222t6αГ(3α+1)2+43Г(2α+1)2t8αГ4(α+1)Г(4α+1)2+24.1778Г(2α+1)2t6αГ(α+1)4Г(3α+1)2+163Г(3α+1)2t8αГ(2α+1)2Г(α+1)2Г(4α+1)2. |
Example 2.
CDαty(t)=y(t)−y2(t),0<α≤1,y(0)=B, | (3.9) |
B Exp(λ=3). |
In this context, where B denotes a random variable with an exponential distribution, solve the local fractional order Riccati differential equation given the initial condition by utilizing the Elzaki-Adomian decomposition method and examine the probabilistic features.
Solution:
Should the Elzaki-Adomian decomposition technique be employed on Eq (3.9),
y0=y(0)+E−1[vαE[0]],yn+1=−E−1[vαE[An]], |
y0=B+E−1[vα0]=B+0=B. |
For n=0,
y1=−E−1[vαE[A0]], |
A0=N(y0)=y02=B2, |
y1=−E−1[vαE[B2]]=−E−1[vα+2B2]=−B2E−1[vα+2]=−B2tαГ(α+1), |
A1=y1N'(y0)=2y0y1=2(B)(−B2tαГ(α+1))=−2B3tαГ(α+1). |
For n=1,
y2=−E−1[vαE[A1]]=−E−1[vαE[−2B3tαГ(α+1)]]=−E−1[vα(−2B3Г(α+1)Г(α+1)vα+2)]=E−1[2B3v2α+2]=2B3t2αГ(2α+1), |
A2=y2N'(y0)+y122!N''(y0)=2y0y2+y21 |
=4B4t2αГ(2α+1)+B4t2αГ(α+1)2. |
For n=2,
y3=−E−1[vαE[A2]]=−E−1[vαE[4B4t2αГ(2α+1)+B4t2αГ(α+1)2]]=−E−1[vα(4B4Г(2α+1)v2α+2Г(2α+1)+B4Г(2α+1)v2α+2Г(α+1)2)]=−E−1[(4B4v3α+2+B4Г(2α+1)v3α+2Г(α+1)2)]=−4B4t3αГ(3α+1)−B4Г(2α+1)t3αГ(α+1)2Г(3α+1), |
y(t)=y0+y1+y2+y3+…=B−B2Г(α+1)tα+2B3Г(2α+1)t2α−(4B4Г(3α+1)+B4Г(2α+1)Г(α+1)2Г(3α+1))t3α+…, | (3.10) |
solution is obtained.X Exp(λ) is a random variable with exponential distribution, the moment generating function [42,43].
MX(t)=E[etX]=λλ−t. |
The expected value and variance of the random variable B Exp(λ),
E[B]=1λ,E[B2]=2λ2,E[B3]=6λ3,E[B4]=24λ4, |
E[B5]=120λ5,E[B6]=720λ6,E[B7]=7!λ7,E[B8]=8!λ8, |
were obtained with the help of the moment generating function.
From the equation Var(X)=E(X2)−[E(X)]2,
Var[B]=1λ2,Var[B2]=20λ4,Var[B3]=684λ6,Var[B4]=39744λ8 |
is found [42,43]. Let us find the expected value and variance of the expression (3.10).
E(y(t))=E(B)−E(B2)Г(α+1)tα+2E(B3)Г(2α+1)t2α−(4Г(3α+1)+Г(2α+1)Г(α+1)2Г(3α+1))E(B4)t3α+…=1λ−2λ2Г(α+1)tα+12λ3Г(2α+1)t2α−(4Г(3α+1)+Г(2α+1)Г(α+1)2Г(3α+1))24λ4t3α+… |
The expected value for the special value λ=3 is
E(y(t))=13−232Г(α+1)tα+1233Г(2α+1)t2α−(4Г(3α+1)+Г(2α+1)Г(α+1)2Г(3α+1))2434t3α+… |
Var(y(t))=Var(B)+(tαГ(α+1))2Var(B2)+(2t2αГ(2α+1))2Var(B3)+(4Г(3α+1)+Г(2α+1)Г(α+1)2Г(3α+1))2t6αVar(B4)=1λ2+(tαГ(α+1))220λ4+(2t2αГ(2α+1))2684λ6+(4Г(3α+1)+Г(2α+1)Г(α+1)2Г(3α+1))239744λ8t6α. |
For the special value λ=3, the variance is
Var(y(t))=132+(tαГ(α+1))22034+(2t2αГ(2α+1))268436+(4Г(3α+1)+Г(2α+1)Г(α+1)2Г(3α+1))23974438t6α. |
Example 3.
CDαty(t)=y2(t)+2y(t)+1,0<α≤1,y(0)=C, | (3.11) |
C N(μ=5,σ2=1). |
In this context, where C is a random variable following a normal distribution, solve the local fractional order Riccati differential equation given the initial condition by utilizing the Elzaki-Adomian decomposition method and examine the probabilistic characteristics.
Solution:
The Elzaki-Adomian decomposition method is used to Eq (3.11).
y0=y(0)+E−1[vαE[1]], |
yn+1=E−1[vαE[An]]+E−1[vαE[qyn]],n=0,1,2,… |
y0=C+E−1[vαv2]=B+E−1[vα+2]=C+tαГ(α+1). |
For n=0,
y1=E−1[vαE[A0]]+E−1[vαE[y0]], |
A0=N(y0)=y02=C2+2CtαГ(α+1)+t2αГ2(α+1), |
y1=E−1[vαE[C2+2CtαГ(α+1)+t2αГ2(α+1)]]+E−1[vαE[C+tαГ(α+1)]]=E−1[vα{C2v2+2Cvα+2+1Г2(α+1)Г(2α+1)v2α+2}]+E−1[vα{Cv2+vα+2}]=E−1[C2vα+2+2Cv2α+2+v3α+2Г(2α+1)Г2(α+1)]+E−1[Cv2+α+v2α+2]=C2tαГ(α+1)+2Ct2αГ(2α+1)+Г(2α+1)Г2(α+1)Г(3α+1)t3α+CtαГ(α+1)+t2αГ(2α+1). |
For n=1,
y2=E−1[vαE[A1]]+E−1[vαE[y1]], |
A1=y1N'(y0)=2y0y1=2(C+tαГ(α+1))((C2+C)tαГ(α+1)+(2C+1)t2αГ(2α+1)+Г(2α+1)Г2(α+1)Г(3α+1)t3α)=2((C3+C2)tαГ(α+1)+(2C2+CГ(2α+1)+C2+CГ(α+1)2)t2α+(CГ(2α+1)Г2(α+1)Г(3α+1)+(2C+1)Г(2α+1)Г(α+1))t3α+Г(2α+1)t4αГ3(α+1)Г(3α+1)), |
y2=E−1[vαE[2((C3+C2)tαГ(α+1)+(2C2+CГ(2α+1)+C2+CГ(α+1)2)t2α+(CГ(2α+1)Г2(α+1)Г(3α+1)+(2C+1)Г(2α+1)Г(α+1))t3α+Г(2α+1)t4αГ3(α+1)Г(3α+1))]] |
+E−1[vαE[(C2+C)tαГ(α+1)+(2C+1)t2αГ(2α+1)+Г(2α+1)Г2(α+1)Г(3α+1)t3α]] |
=2E−1[(C3+C2)Г(α+1)v2α+2Г(α+1)+(2C2+CГ(2α+1)+C2+CГ(α+1)2)Г(2α+1)v3α+2+(CГ(2α+1)Г2(α+1)Г(3α+1)+(2C+1)Г(2α+1)Г(α+1))Г(3α+1)v4α+2+2Г(2α+1)Г(4α+1)v5α+2Г3(α+1)Г(3α+1)] |
+E−1[(C2+C)v2α+2+(2C+1)v3α+2+Г(2α+1)v4α+2Г2(α+1)], |
=(2C3+2C2)t2αГ(2α+1)+(4C2+2CГ(2α+1)+2C2+2CГ(α+1)2)Г(2α+1)t3αГ(3α+1) |
+(2CГ(2α+1)Г2(α+1)Г(3α+1)+(4C+2)Г(2α+1)Г(α+1))Г(3α+1))t4αГ(4α+1) |
+4Г(2α+1)Г(4α+1)t5αГ3(α+1)Г(5α+1)Г(3α+1) |
+(C2+C)t2αГ(2α+1)+(2C+1)t3αГ(3α+1)+Г(2α+1)t4αГ2(α+1)Г(4α+1), |
y(t)=y0+y1+y2+…=C+tαГ(α+1)+(C2+C)tαГ(α+1)+(2C+1)t2αГ(2α+1)+Г(2α+1)Г2(α+1)Г(3α+1)t3α+(2C3+2C2)t2αГ(2α+1)+(4C2+2CГ(2α+1)+2C2+2CГ(α+1)2)Г(2α+1)t3αГ(3α+1)+(2CГ(2α+1)Г2(α+1)Г(3α+1)+(4C+2)Г(2α+1)Г(α+1))Г(3α+1))t4αГ(4α+1)+4Г(2α+1)Г(4α+1)t5αГ3(α+1)Г(5α+1)Г(3α+1)+(C2+C)t2αГ(2α+1)+(2C+1)t3αГ(3α+1)+Г(2α+1)t4αГ2(α+1)Г(4α+1)+⋯ | (3.12) |
The characteristics of the random variable X follow a normal distribution, denoted as X N(μ,σ2). Utilizing the moment generating function of the normal distribution
Mx(t)=E[etX]=e(μt+12σ2t2). |
The first and second moments of the random variable C N(μ,σ2) are E[C]=μ,
E[C2]=μ2+σ2,E[C3]=3σ2μ+μ3,E[C4]=3σ4+6σ2μ2+μ4, |
and its variance,
Var[C]=σ2, Var[C2]=2σ4+4σ2μ2, Var[C3]=15σ6+36σ4μ2+9σ2μ44 |
is found [42,43]. Let us find the expected value and variance of the expression (3.12).
E(y(t))=E(C)+tαГ(α+1)+(E(C2)+E(C))tαГ(α+1)+(2E(C)+1)t2αГ(2α+1)+Г(2α+1)Г2(α+1)Г(3α+1)t3α+(2E(C3)+2E(C2))t2αГ(2α+1)+(4E(C2)+2E(C)Г(2α+1)+2E(C2)+2E(C)Г(α+1)2)Г(2α+1)t3αГ(3α+1)+(2E(C)Г(2α+1)Г2(α+1)Г(3α+1)+(4E(C)+2)Г(2α+1)Г(α+1))Г(3α+1))t4αГ(4α+1)+4Г(2α+1)Г(4α+1)t5αГ3(α+1)Г(5α+1)Г(3α+1)+(E(C2)+E(C))t2αГ(2α+1)+(2E(C)+1)t3αГ(3α+1)+Г(2α+1)t4αГ2(α+1)Г(4α+1)+…=μ+tαГ(α+1)+(μ2+σ2+μ)tαГ(α+1)+(2μ+1)t2αГ(2α+1)+Г(2α+1)Г2(α+1)Г(3α+1)t3α+(2(3σ2μ+μ3)+2(μ2+σ2))t2αГ(2α+1)+(4(μ2+σ2)+2μГ(2α+1)+2(μ2+σ2)+2μГ(α+1)2)Г(2α+1)t3αГ(3α+1)+(2μГ(2α+1)Г2(α+1)Г(3α+1)+(4μ+2)Г(2α+1)Г(α+1))Г(3α+1))t4αГ(4α+1)+4Г(2α+1)Г(4α+1)t5αГ3(α+1)Г(5α+1)Г(3α+1)+(μ2+σ2+μ)t2αГ(2α+1)+(2μ+1)t3αГ(3α+1)+Г(2α+1)t4αГ2(α+1)Г(4α+1)+… |
For special values of the expected value is
For special values of the variance is
In Example 1, the graphs of the Elzaki-Adomian method, the precise answer, and the absolute error are illustrated in Figure 1. Figure 2 illustrates the binned expected value through 2D graphical representations within the interval with 1 and Figure 3 depicts consistently organized variance using 2D graphical representations throughout the interval with 1 and .
Figure 4 illustrates 2D graphs of confidence intervals for the lower confidence area, expected value, and higher confidence region for the intervals with 1 and In Example 2, the anticipated value depicted in Figure 5 is illustrated by 2D graphical plots within the interval for 1 and .
Figure 6 illustrates the two-dimensional graphs of the systematically organized variance for values of , and 1 with t ranging from 0 to 4. Figure 7 illustrates the two-dimensional graphs of the confidence intervals for the lower confidence bound, the anticipated value, and the upper confidence area for the intervals and 1, with ] in Example 3. Figure 8 illustrates the two-dimensional graphs of the systematically organized variance for values of and 1, across the interval
Figure 9 illustrates the two-dimensional graphs of the systematically organized variance for values of , and 1, across the interval Figure 10 illustrates two-dimensional plots of confidence intervals for the lower confidence, expected value, and higher confidence regions for the intervals , and 1, with .
In Example 1, the graphs of the Elzaki-Adomian method, the precise answer, and the absolute error are illustrated in Figure 1. The binned anticipated value in Figure 2 is depicted using a two-dimensional graphic. This study presents the Adomian-Elzaki method (AEM) as a novel hybrid approach for addressing random local fractional Riccati differential equations (RLFRDEs). The suggested technique effectively tackled the issues of nonlinearity, unpredictability, and fractional-order derivatives by integrating the strengths of the Adomian decomposition method (ADM) and the Elzaki transform method (ETM). The theoretical framework and numerical findings indicated that AEM is efficient and dependable in solving RLFRDEs, yielding precise approximations with low computing effort. AEM has several benefits over current methodologies, such as ease of implementation, accelerated convergence, and proficiency in managing nonlinearity and unpredictability. These attributes render it a viable contender for extensive applications in engineering, physics, and other fields where fractional modeling is significant.
Future study may concentrate on expanding AEM to encompass systems of stochastic fractional differential equations, investigating its relevance to practical issues in engineering and the physical sciences. Moreover, the integration of AEM with machine learning methodologies or sophisticated computational instruments might enhance its scalability and efficiency, rendering it a more adaptable approach for addressing progressively intricate challenges.
In summary, the Adomian-Elzaki Method is a notable advancement in the numerical resolution of stochastic local fractional differential equations. Its capacity to tackle complex issues with precision and computing efficiency facilitates its use across several scientific and technical domains.
Ph.D. Aydemir contributed to the article in the areas of Conceptualization, Formal Analysis, Methodology, Software; Ph.D. Merdan contributed to the article in the areas of Funding acquisition, Investigation, Supervision, Validation, Writing–review & editing; Ph.D. Demir contributed to the article in the areas of Resources, Visualization, Writing–original draft. All authors have read and approved the final version of the manuscript for publication.
The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.
The authors declare that they have no conflicts of interest.
[1] | Addiction Merriam-Webster Available from: https://www.merriam-webster.com/dictionary/addiction. |
[2] | Deaths from Excessive Alcohol Use in the U.S. Centers for Disease Control and Prevention, 2020 Available from: https://www.cdc.gov/alcohol/features/excessive-alcohol-deaths.html. |
[3] | Overdose Death Rates National Institute on Drug Abuse, 2020 Available from: https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates. |
[4] | Costs of Substance Abuse National Institute on Drug Abuse, 2020 Available from: https://archives.drugabuse.gov/trends-statistics/costs-substance-abuse. |
[5] |
Bettinardi-Angres K, Angres D (2010) Understanding the Disease of Addiction. J Nurs Regul 1: 31-37. doi: 10.1016/S2155-8256(15)30348-3
![]() |
[6] | Alcohol Addiction National Institute on Drug Abuse, 2020 Available from: https://www.drugabuse.gov/drug-topics/alcohol. |
[7] |
Bilbao A, Robinson JE, Heilig M, et al. (2015) A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice. Biol Psychiatry 77: 850-858. doi: 10.1016/j.biopsych.2014.08.021
![]() |
[8] |
Matsumura Y, Stiles KM, Reid J, et al. (2019) Gene Therapy Correction of Aldehyde Dehydrogenase 2 Deficiency. Mol Ther Methods Clin Dev 15: 72-82. doi: 10.1016/j.omtm.2019.08.004
![]() |
[9] |
Kisor DF, Bright DR, Smith TR, et al. Pharmacogenomics Foundations, Competencies, and the Pharmacists' Patient Care Process: APhA (2020) . doi: 10.21019/9781582123127
![]() |
[10] |
Ducci F, Goldman D (2012) The genetic basis of addictive disorders. Psychiatr Clin North Am 35: 495-519. doi: 10.1016/j.psc.2012.03.010
![]() |
[11] |
Maldonado R, Calvé P, García-Blanco A, et al. (2021) Genomics and epigenomics of addiction. Am J Med Genet, Part B 186: 128-139. doi: 10.1002/ajmg.b.32843
![]() |
[12] |
Kranzler HR, Zhou H, Kember RL, et al. (2019) Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. Nat Commun 10: 1499. doi: 10.1038/s41467-019-09480-8
![]() |
[13] |
Hancock DB, Levy JL, Gaddis NC, et al. (2015) Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. Biol Psychiatry 78: 474-484. doi: 10.1016/j.biopsych.2015.01.003
![]() |
[14] |
Hill SY, Tessner KD, McDermott MD (2011) Psychopathology in offspring from families of alcohol dependent female probands: a prospective study. J Psychiatr Res 45: 285-294. doi: 10.1016/j.jpsychires.2010.08.005
![]() |
[15] |
Asimes A, Torcaso A, Pinceti E, et al. (2017) Adolescent binge-pattern alcohol exposure alters genome-wide DNA methylation patterns in the hypothalamus of alcohol-naïve male offspring. Alcohol 60: 179-189. doi: 10.1016/j.alcohol.2016.10.010
![]() |
[16] | Froehlich JC (1997) Opioid peptides. Alcohol Health Res World 21: 132-136. |
[17] |
Patriquin MA, Bauer IE, Soares JC, et al. (2015) Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. Psychiatr Genet 25: 181-193. doi: 10.1097/YPG.0000000000000095
![]() |
[18] | Nutt D (2016) Mechanisms of Addiction. London Centre for Neuropsychopharmacology: Tocris Bioscience . |
[19] |
Anderson RI, Becker HC (2017) Role of the dynorphin/kappa opioid receptor system in the motivational effects of ethanol. Alcohol: Clin Exp Res 41: 1402-1418. doi: 10.1111/acer.13406
![]() |
[20] |
Mucha RF, Herz A (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86: 274-280. doi: 10.1007/BF00432213
![]() |
[21] |
Nylander I, Hyytiä P, Forsander O, et al. (1994) Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems. Alcohol: Clin Exp Res 18: 1272-1279. doi: 10.1111/j.1530-0277.1994.tb00118.x
![]() |
[22] |
LeDoux JE (1993) Emotional memory systems in the brain. Behav Brain Res 58: 69-79. doi: 10.1016/0166-4328(93)90091-4
![]() |
[23] |
Alasmari F, Goodwani S, McCullumsmith RE, et al. (2018) Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence. Prog Neurobiol 171: 32-49. doi: 10.1016/j.pneurobio.2018.10.001
![]() |
[24] |
Trantham-Davidson H, Neely LC, Lavin A, et al. (2004) Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci 24: 10652-10659. doi: 10.1523/JNEUROSCI.3179-04.2004
![]() |
[25] |
Perry JL, Joseph JE, Jiang Y, et al. (2011) Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions. Brain Res Rev 65: 124-149. doi: 10.1016/j.brainresrev.2010.09.001
![]() |
[26] | Clapp P, Bhave SV, Hoffman PL (2008) How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. Alcohol Res Health 31: 310-339. |
[27] |
Leyton M, Vezina P (2014) Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model. Trends Pharmacol Sci 35: 268-276. doi: 10.1016/j.tips.2014.04.002
![]() |
[28] |
Oberlin BG, Dzemidzic M, Tran SM, et al. (2013) Beer flavor provokes striatal dopamine release in male drinkers: mediation by family history of alcoholism. Neuropsychopharmacology 38: 1617-1624. doi: 10.1038/npp.2013.91
![]() |
[29] |
Blum K, Gondré-Lewis MC, Baron D, et al. (2018) Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors. Front Psychiatry 9: 548. doi: 10.3389/fpsyt.2018.00548
![]() |
[30] |
Li TK, Bosron WF (1986) Genetic variability of enzymes of alcohol metabolism in human beings. Ann Emerg Med 15: 997-1004. doi: 10.1016/S0196-0644(86)80118-4
![]() |
[31] |
Setshedi M, Wands JR, Monte SM (2010) Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev 3: 178-185. doi: 10.4161/oxim.3.3.12288
![]() |
[32] | Vaswani M (2019) . ADH and ALDH Polymorphisms in Alcoholism and Alcohol Misuse/Dependence Academic Press, 29-38. |
[33] |
Peng GS, Yin SJ (2009) Effect of the allelic variants of aldehyde dehydrogenase ALDH2*2 and alcohol dehydrogenase ADH1B*2 on blood acetaldehyde concentrations. Hum Genomics 3: 121-127. doi: 10.1186/1479-7364-3-2-121
![]() |
[34] |
Sanchez-Roige S, Palmer AA, Clarke TK (2020) Recent Efforts to Dissect the Genetic Basis of Alcohol Use and Abuse. Biol Psychiatry 87: 609-618. doi: 10.1016/j.biopsych.2019.09.011
![]() |
[35] |
Zhong Y, Dong G, Luo H, et al. (2012) Induction of brain CYP2E1 by chronic ethanol treatment and related oxidative stress in hippocampus, cerebellum, and brainstem. Toxicology 302: 275-284. doi: 10.1016/j.tox.2012.08.009
![]() |
[36] | Chapter 25: Metabolism of Ethanol. Semantic Scholar . |
[37] |
Larson HN, Weiner H, Hurley TD (2005) Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase “Asian” variant. J Biol Chem 280: 30550-30556. doi: 10.1074/jbc.M502345200
![]() |
[38] |
Santoro N, Zhang CK, Zhao H, et al. (2012) Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology 55: 781-789. doi: 10.1002/hep.24806
![]() |
[39] |
Ng E, Lind PM, Lindgren C, et al. (2015) Genome-wide association study of toxic metals and trace elements reveals novel associations. Hum Mol Genet 24: 4739-4745. doi: 10.1093/hmg/ddv190
![]() |
[40] | Bishehsari F, Magno E, Swanson G, et al. (2017) Alcohol and Gut-Derived Inflammation. Alcohol Res 38: 163-171. |
[41] |
Hubacek JA, Adamkova V, Dlouha D, et al. (2012) Fat mass and obesity-associated (FTO) gene and alcohol intake. Addiction 107: 1185-1186. doi: 10.1111/j.1360-0443.2012.03825.x
![]() |
[42] |
Antonio J, Knafo S, Kenyon M, et al. (2019) Assessment of the FTO gene polymorphisms (rs1421085, rs17817449 and rs9939609) in exercise-trained men and women: the effects of a 4-week hypocaloric diet. J Int Soc Sports Nutr 16: 36. doi: 10.1186/s12970-019-0307-6
![]() |
[43] |
Zhou H, Sealock JM, Sanchez-Roige S, et al. (2020) Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. Nat Neurosci 23: 809-818. doi: 10.1038/s41593-020-0643-5
![]() |
[44] |
Ramchandani VA, Umhau J, Pavon FJ, et al. (2011) A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry 16: 809-817. doi: 10.1038/mp.2010.56
![]() |
[45] |
Rinker JA, Fulmer DB, Trantham-Davidson H, et al. (2017) Differential potassium channel gene regulation in BXD mice reveals novel targets for pharmacogenetic therapies to reduce heavy alcohol drinking. Alcohol 58: 33-45. doi: 10.1016/j.alcohol.2016.05.007
![]() |
[46] |
Koyama S, Brodie MS, Appel SB (2007) Ethanol inhibition of m-current and ethanol-induced direct excitation of ventral tegmental area dopamine neurons. J Neurophysiol 97: 1977-1985. doi: 10.1152/jn.00270.2006
![]() |
[47] |
Kendler KS, Kalsi G, Holmans PA, et al. (2011) Genomewide association analysis of symptoms of alcohol dependence in the molecular genetics of schizophrenia (MGS2) control sample. Alcohol Clin Exp Res 35: 963-975. doi: 10.1111/j.1530-0277.2010.01427.x
![]() |
[48] |
Hamilton PJ, Nestler EJ (2019) Epigenetics and addiction. Curr Opin Neurobiol 59: 128-136. doi: 10.1016/j.conb.2019.05.005
![]() |
[49] |
Przybycien-Szymanska MM, Rao YS, Prins SA, et al. (2014) Parental binge alcohol abuse alters F1 generation hypothalamic gene expression in the absence of direct fetal alcohol exposure. PLoS One 9: e89320. doi: 10.1371/journal.pone.0089320
![]() |
[50] |
Mark TL, Kassed CA, Vandivort-Warren R, et al. (2009) Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend 99: 345-349. doi: 10.1016/j.drugalcdep.2008.07.018
![]() |
[51] | Medications Development Program National Institute on Alcohol Abuse and Alcoholism: U.S. Department of Health and Human Services (2019) . |
[52] |
Keung WM, Vallee BL (1993) Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase. Proc Natl Acad Sci U S A 90: 1247-1251. doi: 10.1073/pnas.90.4.1247
![]() |
[53] |
Kushner S, Han D, Oscar-Berman M, et al. (2013) Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot Study. J Addict Res Ther 4. doi: 10.4172/2155-6105.1000153
![]() |
[54] |
Arolfo MP, Overstreet DH, Yao L, et al. (2009) Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol Clin Exp Res 33: 1935-1944. doi: 10.1111/j.1530-0277.2009.01031.x
![]() |
[55] |
Chick J (1999) Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Saf 20: 427-435. doi: 10.2165/00002018-199920050-00003
![]() |
[56] |
Spanagel R, Vengeliene V, Jandeleit B, et al. (2014) Acamprosate produces its anti-relapse effects via calcium. Neuropsychopharmacology 39: 783-791. doi: 10.1038/npp.2013.264
![]() |
[57] |
De Witte P, Littleton J, Parot P, et al. (2005) Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. CNS Drugs 19: 517-537. doi: 10.2165/00023210-200519060-00004
![]() |
[58] |
Ding ZM, Rodd ZA, Engleman EA, et al. (2013) Alcohol drinking and deprivation alter basal extracellular glutamate concentrations and clearance in the mesolimbic system of alcohol-preferring (P) rats. Addict Biol 18: 297-306. doi: 10.1111/adb.12018
![]() |
[59] |
Saellstroem Baum S, Huebner A, Krimphove M, et al. (2006) Nicotine stimulation on extracellular glutamate levels in the nucleus accumbens of ethanol-withdrawn rats in vivo. Alcohol Clin Exp Res 30: 1414-1421. doi: 10.1111/j.1530-0277.2006.00169.x
![]() |
[60] |
Umhau JC, Momenan R, Schwandt ML, et al. (2010) Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study. Arch Gen Psychiatry 67: 1069-1077. doi: 10.1001/archgenpsychiatry.2010.125
![]() |
[61] |
Koob GF, Mason BJ, De Witte P, et al. (2002) Potential neuroprotective effects of acamprosate. Alcohol Clin Exp Res 26: 586-592. doi: 10.1111/j.1530-0277.2002.tb02578.x
![]() |
[62] |
Maisel NC, Blodgett JC, Wilbourne PL, et al. (2013) Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 108: 275-293. doi: 10.1111/j.1360-0443.2012.04054.x
![]() |
[63] | Naltrexone Medication-Assisted Treatment: Substance Abuse and Mental Health Services Administration (2020) . |
[64] | Biernacka JM, Coombes BJ, Batzler A, et al. (2021) Genetic Contributions to Alcohol Use Disorder Treatment Outcomes: A Genome-wide Pharmacogenomics Study. Neuropsychopharmacology . |
[65] |
Gunthorpe MJ, Large CH, Sankar R (2012) The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy. Epilepsia 53: 412-424. doi: 10.1111/j.1528-1167.2011.03365.x
![]() |
[66] |
Li Y, Li Q, Li W, et al. (2019) The polymorphism of dopamine D2 receptor TaqIA gene is associated with brain response to drug cues in male heroin-dependent individuals during methadone maintenance treatment. Drug Alcohol Depend 198: 150-157. doi: 10.1016/j.drugalcdep.2019.01.028
![]() |
[67] | Kroslak T, Laforge KS, Gianotti RJ, et al. (2007) The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem 103: 77-87. |
[68] |
Ritchie T, Noble EP (2003) Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 28: 73-82. doi: 10.1023/A:1021648128758
![]() |
[69] |
Anghelescu I, Germeyer S, Müller MJ, et al. (2001) No association between the dopamine d2 receptor taqi a1 allele and earlier age of onset of alcohol dependence according to different specified criteria. Alcohol Clin Exp Res 25: 805-809. doi: 10.1111/j.1530-0277.2001.tb02283.x
![]() |
[70] |
Berggren U, Fahlke C, Aronsson E, et al. (2006) The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small. Alcohol Alcohol 41: 479-485. doi: 10.1093/alcalc/agl043
![]() |
[71] |
Wang F, Simen A, Arias A, et al. (2013) A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Hum Genet 132: 347-358. doi: 10.1007/s00439-012-1251-6
![]() |
[72] |
Lee SH, Lee BH, Lee JS, et al. (2013) The association of DRD2 -141C and ANKK1 TaqIA polymorphisms with alcohol dependence in Korean population classified by the Lesch typology. Alcohol Alcohol 48: 426-432. doi: 10.1093/alcalc/agt029
![]() |
[73] |
Dahlgren A, Wargelius HL, Berglund KJ, et al. (2011) Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study. Alcohol Alcohol 46: 509-513. doi: 10.1093/alcalc/agr045
![]() |
[74] |
Bond C, LaForge KS, Tian M, et al. (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A 95: 9608-9613. doi: 10.1073/pnas.95.16.9608
![]() |
[75] |
Mahmoud S, Thorsell A, Sommer WH, et al. (2011) Pharmacological consequence of the A118G µ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca2+ channels in humanized mouse sensory neurons. Anesthesiology 115: 1054-1062. doi: 10.1097/ALN.0b013e318231fc11
![]() |
[76] |
Oertel BG, Kettner M, Scholich K, et al. (2009) A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. J Biol Chem 284: 6530-6535. doi: 10.1074/jbc.M807030200
![]() |
[77] | Taqi MM, Faisal M, Zaman H (2019) OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. Pharmgenomics Pers Med 12: 361-368. |
[78] |
Sadee W, Hartmann K, Seweryn M, et al. (2014) Missing heritability of common diseases and treatments outside the protein-coding exome. Hum Genet 133: 1199-1215. doi: 10.1007/s00439-014-1476-7
![]() |
[79] |
Nam HW, Karpyak VM, Hinton DJ, et al. (2015) Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects. Transl Psychiatry 5: e621. doi: 10.1038/tp.2015.120
![]() |